Cardiac injury and stress are consistent with cardiac troponin and BNP elevation in the COVID-19 patient population and could serve as potential predictors for the development of COVID-19 sequelae such as AMI, AKI, HF exacerbation, or pulmonary edema. This evidence concerns the gene NPPB and acute kidney injury.